Get the free Proposal for a Regulation on medicinal products for paediatric use - europarl europa

This document presents a proposal aimed at improving children's health in Europe by increasing the research, development, and authorization of medicinal products for paediatric use. It outlines the

How to fill out proposal for a regulation

How to fill out Proposal for a Regulation on medicinal products for paediatric use

1. Begin by downloading the template for the Proposal for a Regulation on medicinal products for paediatric use from the official regulatory website.
2. Fill in the title section with a clear and concise title related to the regulation.
3. Provide an abstract summarizing the key objectives and significance of the proposal.
4. Include a detailed introduction outlining the current landscape of medicinal products for paediatric use.
5. Define the scope of the regulation, specifying which medicinal products it will cover and any exemptions.
6. Outline the rationale for the regulation, highlighting the need for specific considerations for paediatric use.
7. Detail the proposed regulatory framework, including requirements for clinical trials and safety assessments specific to children.
8. Address any ethical considerations and how they will be managed in the proposed framework.
9. Include a section on implementation, outlining the steps needed to enact the regulation.
10. Provide references and appendices, including any data or studies that support the proposal.
11. Ensure that the document is reviewed for compliance with existing regulations before submission.

Who needs Proposal for a Regulation on medicinal products for paediatric use?

1. Pharmaceutical companies developing medicinal products intended for children.
2. Regulatory authorities responsible for assessing and approving medicinal products.
3. Healthcare professionals involved in prescribing and administering treatments to paediatric patients.
4. Researchers focused on paediatric medicine and drug development.
5. Patients and families seeking safe and effective treatment options for children.

People Also Ask about

What is the EU 746 regulation?

Unsourced material may be challenged and removed. Regulation (EU) 2017/746 (IVDR) is a regulation of the European Union on the placing on the market and putting into service of in vitro diagnostic medical devices (IVD), repealing Directive 98/79/EC (IVDD), which also concerned IVD.

What is the EU kid regulation?

Regulation (EU) No 1286/2014 obliges those who produce or sell investment products to provide retail investors with key information documents (KIDs) about the products. The aim of the regulation is to help investors to understand and compare the key features and risks of these products.

What is the EU pediatric regulation?

The Regulation aims to ensure that medicines for use in children are of high quality, ethically researched and authorised appropriately and improving the availability of information on the use of medicines for children.

What is the EU regulation 273?

This Regulation establishes harmonised measures for the intra-Union control and monitoring of certain substances frequently used for the illicit manufacture of narcotic drugs or psychotropic substances with a view to preventing the diversion of such substances.

What is Article 33 of the Paediatric Regulation?

According to Article 33, the obligation to place on the market applies to (i) a pediatric indication of (ii) an authorized medicinal product that (iii) has already been marketed with other indications.

What is the application for generic medicinal products according to Directive 2001 83 EC?

According to Article 10 (1) of Directive 2001/83/EC the applicant is not required to provide the results of pre-clinical tests and clinical trials if he can demonstrate that the medicinal product is a generic medicinal product of a reference medicinal product which is or has been authorised under Article 6 of Directive

What are the articles 7 and 8 of the Paediatric Regulation?

Since Articles 7 and 8 refer respectively to 'a medicinal product for human use which is not authorised in the Community' and to an 'authorised medicinal product', at the time of submitting a new stand-alone application, it is necessary to establish whether the product applied for is considered or not a 'medicinal

What is the pediatric regulation in the EU?

The Regulation aims to ensure that medicines for use in children are of high quality, ethically researched and authorised appropriately and improving the availability of information on the use of medicines for children.

For pdfFiller’s FAQs

What is Proposal for a Regulation on medicinal products for paediatric use?

It is a legislative proposal aimed at ensuring that medicinal products are appropriately developed and authorized for use in children, addressing their specific health needs and enhancing research into paediatric medicines.

Who is required to file Proposal for a Regulation on medicinal products for paediatric use?

Pharmaceutical companies and sponsors developing medicinal products intended for use in children are required to file this proposal.

How to fill out Proposal for a Regulation on medicinal products for paediatric use?

The proposal must be filled out by providing detailed information on the product's intended paediatric use, the study design, age-specific formulations, and safety data relevant to the paediatric population.

What is the purpose of Proposal for a Regulation on medicinal products for paediatric use?

The purpose is to enhance the availability of safe and effective medicines for children, ensuring they receive appropriate treatment options tailored to their developmental needs.

What information must be reported on Proposal for a Regulation on medicinal products for paediatric use?

The proposal must include details such as the intended use in paediatrics, the rationale for paediatric trials, age groups targeted, results from prior studies, and plans for paediatric investigation.